Clinical trial
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic…
NCT00198133 · Patrick Joseph Loehrer Sr., Other · Completed
Key facts
| NCT number | NCT00198133 |
|---|---|
| Title | Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma |
| Official title | Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma |
| Lead sponsor | Patrick Joseph Loehrer Sr., Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thymoma, Thymic Carcinoma |
| Intervention type | Drug |
| Interventions | Premetrexed (Alimta) |
| Enrollment | 27 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | May 1, 2012 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: